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We report the first laboratory-confirmed case of
Rickettsia mongolotimonae infection in Africa. The patient
sought treatment for an eschar on his toe; lymphangitis,
severe headaches, and fever subsequently developed.
After a regimen of doxycycline, symptoms rapidly resolved.
R. mongolotimonae infection was diagnosed retrospective-
ly by serologic tests and molecular-based detection of the
organism in biopsy specimens of eschar material.  
R
ickettsioses are infections of emerging medical impor-
tance, particularly in southern Africa, where an
increasing number of cases are being encountered among
both residents and tourists (1). Three Rickettsia species
have been associated with human disease in South Africa
to date. Rickettsia conorii has long been recognized as the
agent of Mediterranean spotted fever, and more recently, a
newly recognized species, R. africae, has been identified
as the agent of African tick-bite fever. In 2002, the first
case report of a patient infected with R. aeschlimannii was
published (2). In addition to these recognized pathogens,
Rickettsia species, including R.  mongolotimonae, have
been detected in human-biting arthropods in Africa. This
species (3) was first encountered in Hyalomma asiaticum
ticks in Inner Mongolia in 1991 (4) but has subsequently
been associated with human infections in southern France
(5) and, perhaps of most relevance to this report, has been
detected in H. truncatum ticks collected from cattle in
Niger (6). This species of tick, which at least during its
immature life stages parasitizes migratory birds, is widely
distributed in many African countries, including South
Africa (7).
The Study
In September 2002, a 34-year-old (HIV-seronegative)
construction worker, working near Ellisras in South
Africa’s Northern Province, discovered a lesion on the
inside of the second toe on his right foot (Figure); subse-
quently, severe headaches and high fever developed. He
was examined at a local hospital and found to have lym-
phangitis extending pretibially from the lesion; as a result
of his other symptoms, he was treated for blood poisoning
with ceftriaxone sodium, 1,000 mg once daily. During the
next 3 days, the lesion at the bite site (noted by the exam-
ining physician) remained very sore, and the patient’s right
inguinal lymph node became enlarged and very painful.
The patient then decided to return to his hometown and
sought treatment from his general practitioner (on day 5
after discovery of the lesion). On examination, the lesion
and lymphangitis were clearly visible on the patient’s toe,
although cellulitis and edema were not observed. His
inguinal lymph node had swollen to 3 cm in diameter, and
he was still febrile (38.5°C). Blood samples were then
obtained as well as a biopsy specimen from the lesion. A
regimen of doxycycline, 100 mg per day orally, for 5 days
was prescribed and 1 day’s dosage was administered. The
next day, the patient was afebrile, and the lymphangitis had
completely resolved. 
In the laboratory, a Giemsa stain of a smear prepared
from the patient’s blood showed activated lymphocytes. A
complete blood count showed thrombocytosis (632 x
103/µL), but all other hematologic parameters were within
the normal range. Biochemical findings showed elevated
levels of alanine transaminase (66 IU/L), blood urea nitro-
gen (7.2 g/L), and triglycerides (2.2 mmol/L); and
decreased levels of chloride (96.3 mmol/L) and albumin
(38g/L); all other tests yielded results within the normal
range. Testing of the patient’s serum with the Weil-Felix
test demonstrated an antibody titer (80) only against the
OX2 Proteus antigen, giving presumptive evidence of a
rickettsial infection. As a result, antirickettsial microim-
munofluorescence testing was performed (8). The serum
did not yield significant immunoglobulin (Ig) M titers
against R. conorii or R. africae antigens, but IgG titers of
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64 were found by using both antigens. DNAwas extracted
from the eschar biopsy specimen by using the QIAamp
Tissue kit (QIAGEN GmbH, Hilden, Germany) according
to the manufacturer’s instructions. This DNA extract was
used as template in a previously described polymerase
chain reaction assay targeting a Rickettsia spp.  rOmpA
fragment (9). An amplification product was obtained from
this extract but not from any concurrently processed con-
trol materials. The amplification product was purified; the
nucleic acid sequences of both strands were then deter-
mined. The sequence obtained from these efforts was
found to share >99% similarity with the corresponding
rOmpA fragment of R. mongolotimonae. 
Conclusions
The combination of clinical and laboratory data yielded
strong evidence that the case described here was an infec-
tion of R. mongolotimonae, the first reported in southern
Africa. A single eschar is also typical of R. conorii infec-
tions, but these are characterized by rash (Mediterranean
spotted fever), which the current patient did not have.
Although R. africae infections manifest only rarely as a
rash, they are typified by multiple eschars (10). This case
description is also very similar to that relating to a French
patient infected with R. mongolotimonae, who had lym-
phangitis and inguinal lymphadenopathy. The serologic
findings indicate exposure to a spotted fever group rick-
ettsia rather than to a specific species within this group, but
the near identity of the rOmpAsequence obtained from the
patient’s eschar to that of R. mongolotimonae provides a
clear indication that this species, rather than other spotted
fever group rickettsiae, was present at the site of the tick
bite. Although no tick was found in association with the
patient’s eschar, his infection may have been acquired
from a H. truncatum, as this species is abundant in the
region of the bushveld where the patient had been working
and is known to feed on humans (11).
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